Enhanced dissolution of sildenafil citrate as dry foam tablets
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2017 |
|---|---|
| Enthalten in: |
Pharmaceutical development and technology - (2017), Seite 1-11 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sawatdee, Somchai [VerfasserIn] |
|---|
| Links: |
|---|
| BKL: |
|---|
| doi: |
10.1080/10837450.2017.1281952 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1991426704 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1991426704 | ||
| 003 | DE-627 | ||
| 005 | 20230715034629.0 | ||
| 007 | tu | ||
| 008 | 170303s2017 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10837450.2017.1281952 |2 doi | |
| 028 | 5 | 2 | |a PQ20170501 |
| 035 | |a (DE-627)OLC1991426704 | ||
| 035 | |a (DE-599)GBVOLC1991426704 | ||
| 035 | |a (PRQ)c702-b10b2443b9ec523ec63a7645f70e082290405eb16ef12ba8a8e0251f7660efa0 | ||
| 035 | |a (KEY)0294643220170000000000000001enhanceddissolutionofsildenafilcitrateasdryfoamtab | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Sawatdee, Somchai |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enhanced dissolution of sildenafil citrate as dry foam tablets |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Atipairin, Apichart |4 oth | |
| 700 | 1 | |a Sae Yoon, Attawadee |4 oth | |
| 700 | 1 | |a Srichana, Teerapol |4 oth | |
| 700 | 1 | |a Changsan, Narumon |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceutical development and technology |d Philadelphia, Pa. : Informa Healthcare, 1996 |g (2017), Seite 1-11 |w (DE-627)214124622 |w (DE-600)1331774-X |w (DE-576)435516191 |x 1083-7450 |7 nnns |
| 773 | 1 | 8 | |g year:2017 |g pages:1-11 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1080/10837450.2017.1281952 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.40 |q AVZ |
| 951 | |a AR | ||
| 952 | |j 2017 |h 1-11 | ||